NCT00599118Active, not recruiting
Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 14 Sept 2026
Brief summary (registry, in English)
The purpose of this study is to establish a genebank repository of blood samples and data to generate information about the hereditary (genetic) basis of atrial fibrillation.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1300 (estimated)
- First submitted
- 10 Jan 2008
- Start date
- 1 Aug 2005
- Primary completion date
- 31 Dec 2035
- Lead sponsor
- The Cleveland Clinic
- Diseases
- Atrial fibrillation
- NCT number
- NCT00599118
What you commit to
- Study type: Observational
- Planned participants: 1300
- From 1 Aug 2005 to the primary completion date, 31 Dec 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Male or female at least 18 years old
- Subjects with a history of or current Atrial Fibrillation
- Subjects able to give informed consent Exclusion Criteria for Atrial Fibrillation group: no history of atrial fibrillation
- Male or female at least 18 years old
- Subjects with no history of Atrial Fibrillation
- Subjects able to give informed consent Exclusion Criteria for controls: History of atrial fibrillation
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cleveland Clinical Foundation Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.